Abstract PR16: Genetically engineered T cells redirected against cancer-associated fibroblasts to potentiate immunotherapeutic effects.
Year: 2013
Type: conference-abstract
Source: Cancer Research
Institutions: Baylor College of Medicine, University of Stuttgart
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1993930021
